Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

VitriCell S.A.

VitriCell is a biotechnology company offering innovative and effective solutions for the cryopreservation of even the most sensitive cells. Its unique technology, based on aseptic vitrification in chemically defined media, enables optimal survival and safeguarding of biological properties for most, if not all, cell types currently used in biological research. A spin-off of the University of Liège (ULiège), VitriCell was founded in June 2017 in Liege (Belgium) by Delphine Connan (PhD, DVM, CEO), Prof. Luc Grobet (Embryology ULiège) and Fabien Ectors (CSO, transgenic platform manager ULiège) with initial capital of €100,000 ($122K). Since its creation, VitriCell has been supported by several partners including the Walloon Region, the University of Liège, the WBC incubator and the Entreprendre Wallonie Network. *


Period Start 2017-06-01 established (s-off)
  Predecessor University of Liège (ULG)
Products Industry BIOTECH
  Industry 2 aseptic vitrification technology
Person Person Connan, Delphine (VitriCell 201706– CEO + Co-Founder)
Region Region Liège (Lüttich)
  Country Belgium
  Street 1 Avenue de l’Hôpital
Quartier Hôpital, Bât B34 GIGA
  City 4000 Liège
  Tel + 32-42-876348
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: VitriCell S.A.. (1/23/18). "Press Release: VitriCell Raises Over €1 Million ($1.2M) in Series A Funding". Liège.
Record changed: 2019-08-09


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for VitriCell S.A.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC A October 650x80px

» top